Chemolipiodolization and prostaglandin E1 administration with use of hepatic arterial infusion port for the treatment of hepatocellular carcinoma and liver cirrhosis

Hepato-Gastroenterology

Volumn 43, Issue 11, 1996, Pages 1377-1382

  Kakizoe, Saburo ^a   Kakizoe, Keiji ^a   Kakizoe, Yumiko ^a   Kakizoe, Hiroshi ^a   Kakizoe, Tamako ^a   Kakizoe, Shinobu ^a  

^a Kakizoe Hospital   (Japan)

Author keywords

Chemolipiodolization; Hepatocellular carcinoma; Infusion port; Liver cirrhosis; Prostaglandin

Indexed keywords

ALPHA FETOPROTEIN; ANTINEOPLASTIC AGENT; EPIRUBICIN; IODINATED POPPYSEED OIL; MITOMYCIN C; PROSTAGLANDIN E1;

AGED; ARTICLE; ASCITES; CANCER INHIBITION; CASE REPORT; DRUG EFFICACY; FEMALE; HEPATIC ARTERY; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; PRIORITY JOURNAL;

AGED; ALPROSTADIL; CARCINOMA, HEPATOCELLULAR; CONTRAST MEDIA; FEMALE; HEPATIC ARTERY; HUMANS; INFUSION PUMPS; IODIZED OIL; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE;

EID: 0029960438     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Kanematsu T, Matsumata T, Shirabe K, Yamagata M, Utsunomiya T, Sugimachi K. Lipiodolization as a targeting regional chemotherapy for primary hepatocellular carcinoma. Gann Monograph Cancer Res 1991;38:157-203.
2. Furuta T, Kanematsu T, Kakizoe S, Sugimachi K. Selective effect of doxorubicfn suspended in lipiodol on UX2 carcinoma in rabbits. J Surg Oncol 1988;39:229-234.
3. Kanematsu T, Furuta T, Takenaka K, Matsumata T, Yoshida Y, Nishizaki T, Hasuo K, Sugimachi K. A 5-year experience of lipiodolization: Selective regional chemotherapy for 200 patients with hepatocellular carcinoma. Hepatology 1989;10:98-102.
4. Nakakuma K, Tashiro S, Hiraoka T, Uemua K, Konno T, Miyauchi Y, Yokoyama I. Studies on anticancer treatment with an oily anticancer drug injected into the ligated feeding hepatic artery for liver cancer. Cancer 1983;52:2193-2200.
5. Kobayashi H, Hidaka H, Kajiya Y, Tanoue P, Inoue K, Nakajo M, Shinohara S. Treatment of hepatocellular carcinoma by transarterial injection of anticancer agents in iodized oil suspension or radioactive iodized oil solution. Acta Radiol Diag 1986;27:139-147.
6. Raoul JL, Bourguet P, Bretague JF, Duvauferrier R, Coornaert S, Darnault P, Ramee A, Herry JY Gastard J. Hepatic artery infection of I-131-labeled lipiodol. Part I. Biodistribution study results in patients with hepatocellular caxcinoma and liver metastases. Radiology 1988;168:541-543.
7. Robert A, Nezamis JE, Lancaster C, Hanchar AJ. Cytoprotection of prostaglandin in rats. Prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl and thermal injury. Gastroenterology 1979;77:433-443.
8. Mizogiichi Y, Tsutsui H, Miyajima K, Sakagami J, Seki S, Kobayashi K, Yamamoto S, Morisawa S. The protective effects of prostaglandin El in an experimental massive hepatic cell necrosis model. Hepatology 1987;1184-1188.
9. Sinclair SB, Greig PD, Blendis LM, Abecassis M, Roberts EA, Phillfps MJ, Cameron R, Levy GA. Hiochemical and clinical response of fulminant viral hepatitis to administration of prostaglandin E. J Clin Invest 1989; 84:1063-1069.
10. Greig PD, Woolf GM, Sinclair SB, Abecassis M, Strasberg SM, Taylor BR, Blendis LM, Superina RA, Glynn MFX, Langer B, Levy GA. Treatment of primary liver graft nonfunction with prostaglandin EI. Transplantation 1989;48:447-453.
11. Seelos R, Otto G, Manner M. Prostaglandins synthesis and survival after liver transplantation in pig. Transplant Proc 1991;23:2420.
12. Manner H, Seelos R, Roy K, Runkel N, Otto G. The role of prostaglandins in reperfusion injury after liver transplantation in pigs. Transplant Proc 1991;23:2413.
13. Shimada M, Matsumata T, Taketomi A, Shirabe K, Yamamoto K, Sugimachi K. The role of prostaglandins in hepatic resection. Prostaglandins Leukotrienes 1994;50:65-68.
14. Ogino H. Anti-fibrotic effect of 16,16-dimethyl prostaglandin E2 on carbon tetrachloride-induced hepatic fibrosis in the rat (in Japanese). Acta Hepatol Jpn 1994;35:216-223.
15. Hamilton G, Chow FFP, Hutton RA, Daudona P, Hobbs KEF. The relation ship between prostaglandin activity and pressure in the portal vein. Hepatolagy 1982;2:236-242.
16. Kanematsu T, Maehara Y, Matsumata T, Shirabe K, Akazawa K, Sugimachi K. Human hepatocellular carcinoma sensitivity to antitumor drugs assayed using the succinate dehydrogenase inhibition test. Oncology 1991;48:34-38.